This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Hybrid Event
20-22 May, 2025Steigenberger Wiltcher's, Brussels
Hybrid Event
20-22 May, 2025,
Steigenberger Wiltcher's, Brussels

Thursday 22 May 2025

Bolster Your Commercial Agreements and Define Key Levers for Success Across Licensing, M&A, Joint Ventures and Investments

Tools and Techniques For Effective Commercial Transactions

Stay Up To Date on Life Science Transaction Trends and Deal Landscape

  • Expected deal trends for 2025/2026 in light of current market conditions
  • Issues for deal makers arising from the EU Pharma Package
  • Key update on innovative deal structures, negotiations and provisions

Drive Success in Your Commercial Agreements

  • Navigating the triple impact of FDI, FSR and merger control
  • Key causes of tension when drafting and negotiating deals
  • Governing law, arbitration or court?

Take Away Expert Advice on Latest Deal Structures

  • Hottest trends for AI in (bio)pharma licensing deals
  • Constructing value for AI in IP licensing negotiations
  • Latest developments in platform technology IP licensing